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Abstract
Struma ovarii is a rare form of ovarian neoplasm in a form of mature teratoma and is composed predominantly of
thyroid tissue. In the literature review, there has only been 10 cases of this tumor, associated with ascites and
pleural effusion (Meig’s Syndrome) and increased CA125 so far. In such cases, the tumor mimics malignant ovarian
tumor. In this article, the case of a 72-year-old symptomatic woman with a pelvic mass, pleural and peritoneal
effusion and high level of serum CA125 is presented. Cytological evaluation for the pleural fluid was performed.
She underwent hysterectomy and bilateral salpingo-oophorectomy. The result of pathologic diagnosis is presented
in this paper. The patient was well in postoperative period and paraclinical tests including CA 125 were normal as
well.
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Background
Struma ovarii is a rare form of ovarian neoplasm derived
from germ cells layers in a form of mature teratoma and is
composed predominantly of thyroid tissue. The preopera-
tive diagnosis is generally difficult [1]. Although the vast
majority of these tumors are benign, they can also mimic
malignant ovarian tumors. Elevated tumor markers for a
post-menopausal woman presenting with a multilocular
adnexal mass, ascites, and pleural effusion can be inter-
preted as highly suspicious case of malignancy [2]. The
diagnosis is usually made postoperatively and by the
pathologists. The association of pseudo-Meig’s syndrome
and elevation of CA125 level to struma ovarii is an extre-
mely rare condition [2] that makes it difficult to differenti-
ate from malignancies [3,4]. In some cases, the tumor
produces thyroid hormone and in some cases, hypothyr-
oidism is reported after tumor resection [5].
Case description
A72-year-old woman with a history of gravida 10, para 10
was referred to department of Obstetrics & Gynecology of
Taleghani Hospital. She had a pelvic mass that was from
2 months before, and was admitted to a local hospital
complaining of dyspnea. Her medical history had included
hypertension since 4 years ago and her other medical his-
tory had been normal. In physical examination, she had a
top normal size uterine and palpable mass in lower side of
abdomen. No lymphadenopathy was detected in auxiliary,
supraclavicular or inguinal regions. In paraclinical exami-
nation, chest imagings showed massive pleural effusion on
right side (Figures 1 and 2). The cytological evaluation for
the pleural fluid showed inflammatory cells infiltration
and no malignant changes had been detected. Then a
chest tube was inserted for the patient to reduce the
volume of pleural effusion. The pleural fluid culture for
anaerobic and other organisms and its direct smear for
Mycobacterium Tuberculosis were negative.
Her transvaginal ultrasonography showed multilocular
cystic-solid mass on her right ovary measuring 53 mm in
diameter, with a 6.8 mm internal septae and 19 mm mural
nodule. The low-resistant pattern on the right ovarian
artery was in favor of malignancy (RI = 0.61). There was
also free intraperitoneal fluid in pelvic cavity. The sono-
graphic figure of her mass declared a case of serous
cystadenocarcinoma.
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contrast was performed (Figure 3). The results showed a
multicystic pelvic mass with irregular calcified mural
nodules, measuring 95*120 mm in size that seemed to
be an ovarian cancer. After checking the Tumor
markers, the CA125 was higher than normal range
(607.4 Units/ml).
CA19-9 = 62.72
CA125 = 607.4
Figure 1 Patient’s chest radiograph before (A) and after (B) operation showing massive pleural effusion that is resolved after surgery.
Figure 2 Chest CT scan of the patient demonstrating pleural effusion.
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Inhibin A < 0.1
The patient went through operation. Her abdominal
cavity had about 700 cc of free fluid sent for cytological
examination. The uterine and left ovary was normal.
There was a 9 cm-diameter mass on her right ovary
with vegetative lesions on its surface that was resected
and sent for the frozen section.
The result of frozen study was granulosa cell tumor.
Therefore, the abdomen was explored and no other invol-
vement was detected. Omentectomy was performed which
was intact. The hysterectomy and bilateral salpingo-
oophorectomy was performed for the patient. The perma-
nent pathological report was struma ovarii (Figure 4). The
uterus, left ovary and fallopian tube were histologically
unremarkable and the cytological evaluation of the ascitic
fluid showed no evidence of malignant cells.
The patient recovered normally and went to home on
the fifth postoperative day. After three months of sur-
g e r y ,n oe v i d e n c eo fa s c i t e sa n dp l e u r a le f f u s i o nw a s
detected and the serum level of CA 125 was in the nor-
mal range (9.3 Units/ml); 12 months following the sur-
gery the CA125 level is 12.5 Units/ml, and there is
neither pleural effusion in chest X-ray (Figure 1) nor
ascites or mass in abdominopelvic ultrasonography. The
patient is healthy and TSH level is 1.6 micIU/ml.
Discussion
Mature cystic teratomas prevalence is about 20% of all
ovarian tumors. Thyroid tissue is observed in 5-15% of
dermoid tumors, but in struma ovarii tumor the thyroid
proportion should be more than 50% of the tissue [5].
Struma ovarii is a mono-dermal variant of ovarian tera-
toma, which was first described by Von Klden in 1895
and Gottschalk in 1899 [1]. It contains about 2.7% of
ovarian teratomas [6]. It is usually a benign lesion but
sometimes, malignant transformation could be observed.
Preoperative clinical diagnosis of struma ovarii, is very
difficult. Despite containing thyroid tissue, only 5% of
struma ovarii have features of hyperthyroidism [7].
Ascites has been reported in one-third of cases. How-
ever, the association of ascites and hydrothorax with
this tumor is not common [1]. Meigs first described the
syndrome consisting of ovarian fibroma/thecoma, with
Figure 4 Short title of figure: Microscopic appearance of the
resected tumor. Detailed legend: The tumor was initially diagnosed
as granulosa cell tumor in frozen study but finally turned out to be
Struma Ovarii in permanent study.
Figure 3 Pelvic CT scan of the patient showing the mass in the pelvic cavity.
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consists of pleural effusion, ascites, and benign tumors
of the ovary other than fibromas.
These benign tumors include the tumors of fallopian
tube or uterus, mature teratomas, struma ovarii, and
ovarian leiomyomas [8]. The ascitic and pleural fluids
in Meigs’ and pseudo-Meigs’ syndrome are usually ser-
ous, but may be serosanguinous and can be either
transudative or exudative. In electrophoresis performed
on several cases it has been determined that pleural
and ascitic fluids were similar in nature. Tumor size,
rather than the specific histologic type, is thought to be
the important factor in the formation of ascites and
accompanying pleural effusion. The origin of the effu-
sions remains obscure, although some mechanisms
have been suggested such as active fluid secretion by
the tumor or peritoneum, venous and/or lymphatic
obstruction, low serum protein, inflammatory products,
hormonal stimulation, and tu m o rt o r s i o n[ 8 ] .I nt h el i t -
erature, very few reports have been published on
struma ovarii associated to ascites and high CA125
[1,4,9-11].
Other than malignant ovarian epithelial tissue, CA 125
antigen is found on both healthy and malignant cells of
mesothelial origin (e.g. peritoneal, pleural, pericardial and
endometrial cells) and non-mesothelial cells (e.g. cervical
epithelium, amniotic membrane, etc.) [12]. Elevated
CA125 is therefore reported in many situations involving
these cells, for example ascites or pleural and pericardial
effusions. The mechanism of such elevation in CA125
may include infiltration of peritoneum by malignant cells,
peritoneal stretching by ascites, low clearance of CA125
by liver in cirrhotic patients, and lymphatic absorption of
ascetic fluid full of CA125 antigen. Any condition that
can cause ascites or effusions (e.g. cardiac diseases, hepa-
tic failure, infectious processes or malignancies) can raise
serum CA125 antigen.
We describe an additional case with struma ovarii asso-
ciated with pseudo-Meigs syndrome and high level of CA
125. Serum levels of CA-125 can be elevated in Meig’s
syndrome, but the degree of elevation does not correlate
with malignancy [8]. The elevation of CA 125 that may
be secondary to the presence of ascites was much higher
than that of typically seen with ascites of benign origin.
Association of an ovarian mass with ascites and high
CA 125 level in women generally suggests a malignant
process. Therefore, the present case with the clinical
findings of ascites, hydrothorax, high level of CA 125 and
a large pelvic mass in an elderly woman suggested pelvic
m a l i g n a n c yb e f o r eo p e r a t i o n .A fter surgical resection of
the tumor and pathologic investigation, the benign nat-
ure of the mass became evident and complete remission
of the ascites, hydrothorax, and CA125 was obtained
after surgery without any further treatment. The patient
is on follow-up and now after about 12 months she is
symptom free.
Struma ovarii is usually non functional and only 8% of
patients present with symptoms and signs of hyperthyr-
oidism, as a result of autonomous activation of the thyr-
oid tissue [13]. At presentation our patient had no
findings suggestive of hyperthyroidism and after the
operation she is clinically and biochemically euthyroid
(TSH = 1.6 micIU/mL). It is worth mentioning that the
granulosa-theca cell tumor is probably the most mis-
diagnosed lesion of the female gonad. According to Emil
Novak Ovarian Tumor Registry, lesions misdiagnosed
initially in frozen section study as granulosa cell tumors,
can be recognized as metastatic carcinomas, teratoid
tumors, and poorly differentiated mesothelial tumors
[14]. In this case the mass was initially misdiagnosed as
granulosa cell tumor but finally the diagnosis of struma
ovarii was confirmed.
Conclusion
According to this report, one should know that there are
some benign ovarian masses like Struma Ovarii that
resemble malignant conditions initially based on their clin-
ical or laboratory aspects and morphological appearances.
In the differential diagnosis of an ovarian mass in a
patient presented with ascites, high CA 125 serum and
pleural effusions, but with negative cytologic examina-
tion we should consider these benign gynecological con-
ditions too.
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